Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

AbbVie Inc., consolidated cash flow statement

US$ in millions

12 months ended:	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net earnings	4,286)	4,873)	11,845)	11,549)	4,622)
Depreciation	764)	752)	778)	803)	666)
Amortization of intangible assets	7,622)	7,946)	7,689)	7,718)	5,805)
Deferred income taxes	(1,449)	(2,889)	(1,931)	(898)	(2,325)
Change in fair value of contingent consideration liabilities	3,771)	5,128)	2,761)	2,679)	5,753)
Payments of contingent consideration liabilities	(1,995)	(870)	(164)	(91)	—)
Stock-based compensation	911)	747)	671)	692)	753)
Acquired IPR&D and milestones	2,757)	778)	697)	1,124)	1,376)
Other charges related to collaborations	—)	—)	—)	500)	—)
Gain on divestitures	—)	—)	(172)	(68)	—)
Non-cash litigation reserve adjustments, net of cash payments	508)	(443)	2,243)	163)	(31)
Impairment of intangible assets	4,476)	4,229)	770)	50)	—)
Other, net	(63)	(225)	(150)	(213)	863)
Accounts receivable	207)	66)	(1,455)	(1,321)	(929)
Inventories	(319)	(417)	(686)	(142)	(40)
Prepaid expenses and other assets	361)	(188)	(264)	(197)	134)
Accounts payable and other liabilities	177)	3,840)	1,769)	1,719)	1,514)
Income tax assets and liabilities, net	(3,208)	(488)	542)	(1,290)	(573)
Changes in operating assets and liabilities, net of acquisitions	(2,782)	2,813)	(94)	(1,231)	106)
Adjustments to reconcile net earnings to net cash from operating activities	14,520)	17,966)	13,098)	11,228)	12,966)
Cash flows from operating activities	18,806)	22,839)	24,943)	22,777)	17,588)
Acquisition of businesses, net of cash acquired	(17,493)	—)	(255)	(525)	(38,260)
Other acquisitions and investments	(3,024)	(1,223)	(539)	(1,377)	(1,350)
Acquisitions of property and equipment	(974)	(777)	(695)	(787)	(798)
Purchases of investment securities	(73)	(77)	(1,438)	(119)	(61)
Sales and maturities of investment securities	555)	55)	1,530)	98)	1,525)
Other, net	189)	13)	774)	366)	1,387)
Cash flows from investing activities	(20,820)	(2,009)	(623)	(2,344)	(37,557)
Proceeds from issuance of other short-term borrowings	5,008)	—)	—)	—)	—)
Repayments of other short-term borrowings	(5,008)	—)	—)	—)	—)
Proceeds from issuance of long-term debt	16,963)	—)	2,000)	1,000)	3,000)
Repayments of long-term debt and finance lease obligations	(9,613)	(4,149)	(14,433)	(9,414)	(5,683)
Debt issuance costs	(99)	(38)	—)	—)	(20)
Dividends paid	(11,025)	(10,539)	(10,043)	(9,261)	(7,716)
Purchases of treasury stock	(1,708)	(1,972)	(1,487)	(934)	(978)
Proceeds from the exercise of stock options	214)	180)	262)	244)	209)
Payments of contingent consideration liabilities	—)	(752)	(1,132)	(698)	(321)
Other, net	57)	48)	30)	24)	8)
Cash flows from financing activities	(5,211)	(17,222)	(24,803)	(19,039)	(11,501)
Effect of exchange rate changes on cash and equivalents	(65)	5)	(62)	(97)	(5)
Net change in cash and equivalents	(7,290)	3,613)	(545)	1,297)	(31,475)
Cash and equivalents, beginning of year	12,814)	9,201)	9,746)	8,449)	39,924)
Cash and equivalents, end of year	5,524)	12,814)	9,201)	9,746)	8,449)

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Download chart

Cash flow statement item	Description	The company
Cash flows from operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	AbbVie Inc. cash flows from operating activities decreased from 2022 to 2023 and from 2023 to 2024.
Cash flows from investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	AbbVie Inc. cash flows from investing activities decreased from 2022 to 2023 and from 2023 to 2024.
Cash flows from financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	AbbVie Inc. cash flows from financing activities increased from 2022 to 2023 and from 2023 to 2024.

AbbVie Inc. (NYSE:ABBV)

Cash Flow Statement